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Abstract
Background: An R30 fraction from the growth medium of Aeropyrum pernix was analyzed for the protease that can digest
the pathological prion protein isoform (PrP
Sc) from different species (human, bovine, deer and mouse).
Methodology/Principal Findings: Degradation of the PrP
Sc isoform by the R30 fraction and the purified protease was
evaluated using the 6H4 anti-PrP monoclonal antibody. Fragments from the N-terminal and C-terminal of PrP
Sc were also
monitored by Western blotting using the EB8 anti-PrP monoclonal antibody, and by dot blotting using the C7/5 anti-PrP
monoclonal antibody, respectively. For detection of smaller peptides from incomplete digestion of PrP
Sc, the EB8
monoclonal antibody was used after precipitation with sodium phosphotungstate. Characterization of the purified active
protease from the R30 fraction was achieved, through purification by fast protein liquid chromatography, and identification
by tandem mass spectrometry the serine metalloprotease pernisine. SDS-PAGE and zymography show the purified pernisine
plus its proregion with a molecular weight of ca. 45 kDa, and the mature purified pernisine as ca. 23 kDa. The purified
pernisine was active between 58uC and 99uC, and between pH 3.5 and 8.0. The temperature and pH optima of the
enzymatic activity of the purified pernisine in the presence of 1 mM CaCl2 were 105uC 60.5uC and pH 6.560.2, respectively.
Conclusions/Significance: Our study has identified and characterized pernisine as a thermostable serine metalloprotease
that is secreted from A. pernix and that can digest the pathological prion protein PrP
Sc.
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Introduction
The term ‘prion’ was first introduced by Prusiner in 1982. He
defined it as a small proteinaceous infectious particle that can resist
inactivation by nucleic-acid-modifying procedures. At first, the
research was oriented towards identification of the agent causing
scrapie in sheep and goats. Scrapie is a type of transmissible
spongiform encephalopathy (TSE) that belongs to a group of
diseases that have also been recognized in several other animal
species, as well as in humans: the prion diseases.
It is believed that TSEs develop after the cellular prion protein
(PrP
C) undergoes structural changes. PrP
C is a monomeric,
glycosylated protein that is attached to cell membranes through
a glycosylphosphatidylinositol anchor [1], and it is highly
conserved among mammals [2–5]. It is expressed in different cell
types, with the highest expression levels in the brain of animals and
human. However, its function has not yet been clearly established
[6–16]. The key step in the development of TSEs is the
accumulation of the pathological PrP isoform (PrP
Sc) with a ß-
sheet rich region, unlike the a-helices that are the predominant
secondary structure of PrP
C [17,18].
As a consequence of its conformational characteristics, PrP
Sc has
some unique features, among which there is resistance to protease
digestion, and to detergents, heat, UV and ionization radiation
treatments [19].The PrP
Scisoform thushasanunusual resistance to
conventional chemical and physical decontamination methods,
which raises substantial medical and food-industry considerations
[20–22]. For this reason, several reports on proteolytic decontam-
ination of TSE agents have been published in recent years.
The majority of proteases that have been studied require
additional chemical or physical treatments of brain homogenates
to enhance their ability to digest this PrP
Sc isoform. Pretreatment of
brain homogenates with 0.1 M NaOH or 2% sodium dodecyl
sulfate (SDS) increases PrP
Sc susceptibility towards some commer-
cially available proteases [23,24]. Furthermore, only after PrP
Sc
heat treatment to 115uC can Bacillus licheniformis PWD-1 keratinase
digest PrP
Sc in homogenates of bovine spongiform encephalopathy
(BSE) and scrapie-infected brain [25]. Similarly, after long
incubation times, the thermally denatured amyloid recombinant
ovine PrP
Sc isoform was only partially degraded when incubated
with extracellular proteases from anaerobic thermophilic prokary-
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proteases have been tested for activity against PrP
Sc [27–29].
Recently, some lichen extracts containing unknown serine proteases
have been shown to promote PrP
Sc degradation [30] and some
earthworm proteases in water extracts can successfully degradate
PrP
C [31].
In the present study, we show that a protein fraction prepared from
growth medium (the R30 fraction) in which the hyperthermophilic
marine archaeon Aeropyrum pernix has been cultivated has proteolytic
activity against the PrP
Sc isoform of different species. In Western
blotting and dot blotting, several PrP
Sc fragments were revealed using
monoclonalantibodiesagainstdifferentPrPepitopes.Thisproteolytic
activity is additionally demonstrated by intracerebral bioassays.
Further analysis of this R30 fraction shows that this proteolytic
activity is associated with the serine metalloprotease pernisine.
Materials and Methods
Strain and Growth Conditions
A. pernix strain K1 (JCM 9820) was used in this study. The cells
were grown under aerobic conditions at 92uC in a medium
containing yeast extract (1.0 g/L), peptone (5.0 g/L), Na2-
S2O3.5H2O (1.0 g/L), AZOO reef salt (34 g/L) and HEPES
(20 mM), pH 7.0, as described previously [32].
Preparation and Analysis of the R30 Extracellular Extract
with Proteolytic Activity
A cultivation batch (6.4 L) of A. pernix was stopped after 40 h of
growth, and the cells were removed by centrifugation at 10,0006g for
15 min; the supernatant (growth medium) was then filtered through
45 mma n d2 0mm cellulose nitrate filters. This growth medium was
concentrated ca. 1500-fold using a concentrator (Pall Corp.) with a
10-kDa molecular-weight cut-off, and ultrafiltered using YM10
membranes (Millipore). This concentrated growth medium was
loaded onto a Superdex 200 preparative grade gel filtration column
(GE Healthcare), equilibrated with phosphate-buffered saline (PBS),
pH 8.0. Fast protein liquid chromatography (FPLC) was carried out
on an A ¨kta Explorer system (GE Healthcare). The fractions with the
highest proteolytical activities were collected and ultrafiltered using
Amicon Ultra-4 filters (Millipore). All of the purification procedures
were performed at 4uC. For the analysis of the protein content of this
R30 fraction, it was subjected to SDS polyacrylamide gel electro-
phoresis (SDS-PAGE), according to Laemmli et al.[ 3 3 ] .A f t e r
separation on 12% SDS polyacrylamide gels, the protein bands were
stained with Simplyblue dye (Invitrogen), according to the standard
manufacturer protocol. The protein molecular weights were calcu-
lated from the SDS-PAGE using the BioNumerics program (Applied
Maths NV, Belgium). Selected protein bands were analyzed by
Orbitrap–tandem mass spectrometry (MS/MS) (at the Jozef Stefan
Institute, Slovenia).
Immunodetection of PrP Fragments after Treatment with
the R30 Fraction and Purified Pernisine
The proteolytic activity of the R30 fraction against PrP
Sc was
tested on the post-nuclear fractions from several uninfected and
infected brain homogenates. These post-nuclear fractions were
prepared by homogenization of the brain tissue (10%; w/v) in
PBS, with added 0.5% NP-40 and 0.5% sodium deoxycholate,
using a HT1000 Potter homogenizer, with aliquots stored at –
80uC. Prior to use, the brain homogenates were cleared of
particulate matter by centrifugation at 5,0006g for 5 min,
followed by centrifugation for 10 min at 15,0006g to remove
the nuclear fraction.
The reaction mixture (final volume, 15 mL) contained the R30
fraction (0.2 U; see below), 3 mL post-nuclear fraction, and the
appropriate amount of PBS. These mixtures were incubated at
92uC for the times specified. A reference reaction mixture that
contained 0.75 mg proteinase K instead of the R30 fraction was
incubated in parallel at 37uC.
The reactions were stopped by the addition of 26 Laemmli
sample buffer, and 20 mL was used for standard 12% SDS-PAGE.
The gels were run at 120 V for 55 min, and then the proteins were
transferred to nitrocellulose membranes using Towbine buffer
(25 mM Tris, 192 mM glycine, 20% methanol, pH 8.3) at
200 mA for 75 min, in a semi-dry blot system (BioRad). The
nitrocellulose membranes were then incubated in the blocking
solution (TBS: 50 mM Tris, 150 mM NaCl, pH 7.6, with 0.1%
[v/v] Tween 20 and 5% [w/v] nonfat milk), overnight at 4uC,
according to C ˇurin S ˇerbec et al. [34]. Alternatively, a reaction
mixture containing the post-nuclear fraction diluted 20-fold in
PBS and an appropriate amount of the R30 fraction (0.2 U per
3 mL post-nuclear fraction) was incubated at 92uC for 20 min.
Whole-brain homogenates (2 mL) from TSE infected human,
bovine and mouse, and from human Alzheimer’s disease brain,
were incubated without or with proteinase K (0.50 mg), for 20 min
at 37uC, or without or with the purified pernisine (0.2 U, with the
addition of 1 mM CaCl2), for 20 min at 92uC. The proteins from
the 50-mL reaction mixtures were then dot blotted using standard
procedures (BioRad).
The presence of all PrP isoforms and peptides was revealed on
the nitrocellulose membranes by immunodetection using the 6H4
anti-PrP monoclonal antibody [35]. The further specific mono-
clonal antibodies used were: the EB8 anti-PrP monoclonal
antibody that recognizes an N-terminal epitope (between residues
20 and 40 of human PrP; our unpublished data); and the C7/5
anti-PrP monoclonal antibody that recognizes a C-terminal
epitope (residues 214 to 226 of human PrP [36]). These primary
antibodies were revealed using horseradish-peroxidase-conjugat-
ed anti-mouse antibodies (Amersham) as the secondary antibod-
ies. The primary antibodies were diluted in TBST (TBS with
0.1% [v/v] Tween 20 and 1% [v/v] nonfat milk) to final
concentrations of 0.2 mg/mL (6H4) or 5 mg/mL (EB8 and C7/
5). The secondary antibodies were 1500-fold diluted in TBST
buffer. Incubations of the membranes with these primary and
secondary antibodies were carried out for 1 h at 24uC, with
constant agitation. The overnight blocking and the incubation
steps were followed by washing steps in TBS with 0.1% (v/v)
Tween 20, as two rapid washes, one 15-min wash, and two 5-
min washes. After the final washing step, the standard ECL
procedure was performed (GE Healthcare), followed by 15 min
exposure of the membrane to an ECL film.
Phosphotungstate Precipitation
The brain-tissue homogenates (post-nuclear fractions; see
above) were subjected to proteinase K or R30 fraction digestion
before the sodium phosphotungstate (NaPTA) precipitation, with
125 mL digested for 20 min with either proteinase K at 37uC (final
concentration, 50 mg/mL) or the R30 fraction at 92uC. For the
negative control, aliquots of 25 mL post-nuclear fraction were
incubated in the absence of any enzyme activity at 37uC and
92uC. The NaPTA precipitation was performed according to
Wadsworth et al. [37]. An equal volume of 4% sarcosyl in PBS was
added to the enzyme-digested samples and incubated for 15 min
at 37uC, with constant agitation. Then, the samples were adjusted
to a final concentration of 500 U/mL benzonase (Sigma Aldrich)
and 1 mM MgCl2 (Sigma Aldrich), and incubated for 30 min at
37uC. Then 27.5 mL PBS and 47.5 mL complete TM-Mini 76
Enzymatic Degradation of PrP
Sc
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39548stock (Roche) were added to the enzyme-treated samples, and 5-
fold lower amounts to the non-treated samples. Subsequently,
5 mL 4% (w/v) sodium phosphotungstatic acid in 170 mM MgCl2
(pH 7.4) was added to the final concentration of 0.3% (w/v)
sodium phosphotungstatic acid. The samples were incubated for
30 min at 37uC, with constant agitation, and then centrifuged
(140006g, 30 min). The precipitation was also performed for the
control samples, with 5-fold lower volumes of reagents used, as
compared to the samples treated with the enzymes. The
supernatants from the precipitation were discarded, and the
pellets were resuspended in 20 mL 0.1% sarcosyl in PBS (pH 7.4).
Finally, 10 mLo f3 6 loading buffer, containing 16% 2-mercap-
toethanol, was added.
Additional Purification of the R30 Proteolytically Active
Fraction
The proteolytically active R30 fraction from the Superdex 200
preparative grade gel filtration column was further purified, to
identify the active protease(s). The next step of purification/
separation of this fraction was using a MonoQ 4.6/100 ion-
exchange gel column (GE Healthcare) on a FPLC system. The
column was eluted with 50 mM Tris/HCl, pH 8.0, with a linear
gradient of NaCl from 0.0 M to 1.0 M at a flow rate of 1 mL/
min. The active fraction, which eluted at around 0.5 M NaCl, was
ultrafiltered and concentrated with an Ultra-15 Amicon centrif-
ugal filter unit (Millipore) with PBS. The purity of the enzyme
activity was analyzed by 12% SDS-PAGE. The proteolytic activity
was tested on zymogram gels, as described below.
Qualitative Proteolytic Activity Assay
To assay the proteolytic activity of specified samples, we
followed the zymography procedure described by Foophow et al.
[38], which is based on zymogram gels (12% SDS-PAGE gels
containing 0.1% [w/v] casein (Sigma Aldrich) as substrate).
Samples (0.5 mg) were applied to these casein-containing
zymogram gels and electrophoresed at a constant 125 V for
70 min. The gels were then soaked in 2.5% (v/v) Triton X-100
on a shaker for 60 min, washed twice with 50 mM Tris/HCl,
pH 8.0, containing 1 mM CaCl2, and incubated in the same
buffer for 4 h at 80uC. The proteolytic activity was visualized as
clear bands on the gel against a blue background, using
Simplyblue staining.
Quantitative Proteolytic Activity Assay
The proteolytic activities of specified fractions were determined
using the azocasein assay described by Charney et al. [39], with
some modifications. The protein concentrations were determined
by the Bradford method [40], using the BioRad Protein Assay
(BioRad) with bovine serum albumin as the standard. Briefly, the
reaction mixtures were prepared in PCR tubes and contained
40 mL 50 mM Tris/HCl, pH 8.0, 50 mL 0.2% (w/v) azocasein
(Sigma Aldrich) in the same buffer and 10 mL sample (1 mg
protein). After 20 min at 92uC, the reactions were stopped by
adding 50 mL 15% (w/v) trichloroacetic acid. The samples were
kept at 4uC for 10 min, and then centrifuged at 100006g for
10 min. The absorbance of the supernatants was measured at
366 nm against the blank (complete reaction mixture stopped
before incubation at 92uC). One unit of protease activity was
defined as the amount of enzyme that yielded an increase in A366
of 0.1 O.D. under the relevant experimental conditions. The
samples were assayed as triplicates and the standard errors
calculated. The maximal activity was defined as the highest
activity of the purified pernisine in the absence of CaCl2.
Protease Activity
The azocasein assay described above was used to determine the
proteolytic activity optimum of the purified pernisine under the
different experimental conditions. Initially, the optimum proteolytic
activity of the purified pernisine in the presence of different CaCl2
concentrations (0 to 8 mM) was investigated. Then, the effects of
different NaCl concentrations (0 to 500 mM) on the proteolytic
activity of the purified pernisine were examined. To determine the
effects of CaCl2 on the temperature optimum, the activity of the
purified pernisine was measured in the temperature range from
50uCt o1 5 0 uC in the absence and presence of 1 mM CaCl2.A
heating block (StarLab, Germany) was used to incubate the reaction
mixture for 20 min at 50uC, 70uC, 80uC, 90uC, 99uC, 110uC,
120uC, 130uC and 150uC. To avoid evaporation, the tubes were
sealed withparafilm.Asimilarexperimentwasperformed forthepH
range from pH 2 to pH 13. The buffers used were: 50 mM glycine/
HCl (pH 2 to 4), 50 mM HEPES (pH 6 to 8) and 50 mM glycine/
NaOH (pH 9 to 13). The pH values at the incubation temperature
(92uC) were calculated taking into account the dpH/dT coefficients
[41]. Similarly, the thermostability of pernisine was determined by
the enzymatic activity measurement at different temperatures (70uC
and 90uC) in the presence and absence of Ca
2+ ions at pH 8.0 for
prolonged incubation times (0 min, 20 min, 40 min, 120 min) was
measured as previously described Catara et al. [42].
The effects on the proteolytic activity of inhibitors, reductants,
denaturants and detergent were also analyzed. Samples of the
purifiedpernisine inthereaction mixturewerepreincubated at room
temperature for 10 min prior to the azocasein assays. The inhibitors
studied were ethylenediaminetetraacetic acid (EDTA; 1, 10 mM),
ethylene glycol-bis(b-aminoethyl ether)-N, N, N, N-tetraacetic acid
(EGTA; 1, 5 mM), iodoacetamide (IAA; 1 mM) and phenylmethyl-
sulfonyl fluoride (PMSF; 1, 10 mM); the reductants were 2-
mercaptoethanol (1%, 5%) and dithiothreitol (DTT; 1, 5 mM); the
denaturants were urea (1, 4 M) and guanidinium hydrochloride
(GdnHCl; 1, 4 M); and the detergent was SDS (0.1%, 3.0%).
Protein Identification by Tandem Mass Spectrometry
Selected protein bands from the SDS-PAGE were destained and
reduced in 25 mM NH4HCO3 containing 10 mM DTT, for 45 min
at 56uC. They were then alkylated in the same buffer containing
55 mM IAA for 30 min at room temperature. The gel pieces were
washed with 25 mM NH4HCO3 and dried. Trypsin solution
(12.5 ng/mL trypsin in 25 mM NH4HCO3) was added, and the
samples were incubated overnight at 37 uC. The digested peptides
were extracted from the gel with a mixture of 50% acetonitrile and
5% formic acid. The extracts were concentrated to 10 mLu s i n ga
Concentrator (Eppendorf model 5301) and analyzed by MS/MS.
The MS/MS analysis was performed using a Proxeon EASY-
nLC II HPLC unit (Thermo Scientific) coupled to a LTQ
Orbitrap Velos ETD mass spectrometer. The peptide samples
were loaded onto an Aquasil C18 Picofrit HPLC column (New
Objective), and eluted with a 30-min 3% to 50% acetonitrile
gradient at a 350 nL/min flow rate. The mass spectra were
analyzed by Proteome Discoverer (Thermo Scientific) using a
nonredundant NCBI protein database. Positive hits were re-
evaluated by Scaffold (Proteome Software). Hits that showed
100% probability were considered as significant.
Results
Initial Temperature- and Time-dependent Digestion of
PrP
Sc by the R30 Fraction
The effectiveness of the R30 fraction from the Superdex 200
preparativegradegelfiltrationcolumnfortheproteolyticremovalof
Enzymatic Degradation of PrP
Sc
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39548PrP
Sc from Creutzfeldt-Jakob disease (CJD)-infected brain homog-
enates was first estimated. This was followed as the time-dependent
degradationofthePrP
ScisoforminthesupernatantoftheCJDbrain
homogenates. From Figure 1, it can be seen that the PrP
Sc in the
supernatant of these brain homogenates is stable over 60 min at
92uCintheabsenceoftheR30fraction(Fig.1,lane1).Afteraddition
oftheR30fractiontothereactionmixture,PrP
Scwasnotdetectedin
the supernatant after just 10 min of incubation at 92uC (Fig. 1, lane
3). On this basis, all of the further incubations were carried out for
20 minattheappropriatetemperatures.Thisproteolysiswasdueto
ahyperthermophilicproteaseintheR30fraction,asthedegradation
ofPrP
Scwasnotcompletewhenthereactionmixturewasincubated
at room temperature (Fig. 1, lane 2).
Digestion of PrP
Sc by the R30 Fraction
Digestion of the cellular prion protein, PrP
C, by the R30
fraction at 92uC was comparable with that of proteinase K at 37uC
(Fig. 2). Proteinase K and the R30 fraction both removed the
immunoreactive material from the reaction mixtures to below the
detection level of Western blotting (Fig. 2, lanes 2, 4, respectively).
Furthermore, a significant difference in proteolytic degradation
was obtained when supernatants of CJD brain homogenates were
used (Fig. 2, panel A1). After 20 min of incubation of the PrP
Sc
samples with proteinase K, there was little digestion of the
immunoreactive material (Fig. 2, lanes 5, 6). On the contrary, with
the R30 fraction, the immunoreactive material from the reaction
mixtures was again below the detection level of Western blotting
(Fig. 2, lanes 7, 8). The proteolytic activity of the R30 fraction also
did not depend on the species of origin of the PrP used (Fig. 2,
panels A1, B, C). The activities of proteinase K and the R30
fraction were also tested against the protein from amyloid plaques
typical for human Alzheimer’s disease (Fig. 2, panel A2). Here,
again, the R30 fraction completely digested the immunoreactive
material from the reaction mixtures to below the detection level of
Figure 1. Temperature- and time-dependent degradation of
PrP
Sc by the R30 fraction, in post-nuclear homogenates from
CJD-infected brain. A post-nuclear homogenate from CJD-infected
brain was incubated as indicated, without (lane 1) or with (lanes 2–6)
the R30 fraction from the Superdex 200 preparative grade gel filtration
column, under the following conditions: at room temperature for
60 min (lane 2; RT); or at 92uC for 10 min (lane 3), 20 min (lane 4),
40 min (lane 5), and 60 min (lanes 1, 6). The proteins were separated by
SDS-PAGE and transferred to nitrocellulose membrane. The immuno-
reactive species were detected as described in Materials and Methods,
with the 6H4 anti-PrP monoclonal antibody used as the primary
antibody.
doi:10.1371/journal.pone.0039548.g001
Figure 2. Digestion of PrP
C and PrP
Sc of different species by the R30 fraction. Post-nuclear homogenates from human (A), bovine (B) and
mouse (C) uninfected (lanes 1–4), TSE infected (lanes 5 to 8) and Alzheimer’s disease (lanes 9 to 12) brains were incubated as indicated, without (lanes
1, 5, 9) or with (lanes 2, 6, 10) 0.75 mg proteinase K (PK), for 20 min at 37uC, or without (lanes 3, 7, 11) or with (lanes 4, 8, 12) the R30 fraction from the
Superdex 200 preparative grade gel filtration column, for 20 min at 92uC. The proteins were separated by SDS-PAGE and transferred to nitrocellulose
membranes. The immunoreactive species were detected as described in Materials and Methods, with the 6H4 anti-PrP monoclonal antibody used as
the primary antibody.
doi:10.1371/journal.pone.0039548.g002
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same was also seen for proteinase K (Fig. 2, panel A2, lanes
9, 10).
Detection of Smaller sized Peptides Following PrP
Sc
Digestion
The degradation of PrP
Sc by the R30 fraction was further
examined with the use of two monoclonal antibodies against
different epitopes of PrP
Sc, for the N-terminal (EB8) and the C-
terminal (C7/5). For the detection of smaller peptides that would
result from incomplete digestion of PrP
Sc at the N-terminal with
the EB8 antibodies, no immunoreactive material (and hence no
smaller N-terminal fragments) were detected with Western blotting
(Fig. 3A, lanes 2–5). Furthermore, even in reaction mixtures with
up to 4-fold the original amount of PrP
Sc-infected brain
homogenate supernatant there were still no smaller degradation
products of PrP
Sc detected following this treatment with the R30
fraction (Fig. 3A, lane 5).
Similarly, for the detection of smaller peptides that would result
from incomplete digestion of PrP
Sc at its C-terminal, the C7/5
monoclonal antibody was used. Here, dot blot analysis was used,
as the C7/5 monoclonal antibody does not bind to the denatured
epitope. The PrP
Sc isoform was confirmed only in the control
reaction mixture, while the addition of the R30 fraction also
resulting in the complete disappearance of the signal in the dot
blot analysis (Fig. 3B). The appropriate controls with the 6H4
monoclonal antibody and the secondary antibodies alone were
incorporated in the same experiment, and gave the expected
results (Fig. 3B). The 6H4 monoclonal antibody reacted only with
the undigested PrP
Sc samples, and the secondary antibodies did
not react with either of these samples.
The extent of degradation of PrP
Sc by the R30 fraction was
further estimated using NaPTA precipitation. The post-nuclear
fractions from CJD-infected brain homogenates were incubated
for 20 min in the absence and presence (5-fold greater volume) of
proteinase K (at 37uC) or the R30 fraction (at 92uC), and then
subjected to the NaPTA precipitation procedure (Fig. 4, lanes 1, 2,
and lanes 3, 4, respectively). The proteins were separated by SDS-
PAGE and then transferred to nitrocellulose membranes. The
immunoreactive species were detected using the 6H4 monoclonal
antibody. From the intensities of the bands in Figure 4 for lanes 1
and 3, although there was less human PrP
Sc in the sample than in
that incubated with the R30 fraction at 92uC (Fig. 4, lane 3), as
compared to proteinase K at 37uC (Fig. 4, lane 1), there were no
detectable fragments from the proteolytic degradation of PrP
Sc by
the R30 fraction in this Western blotting (Fig. 4, lane 4).
Figure 3. Detection of smaller sized peptides as a result of
PrP
Sc digestion. A. Post-nuclear homogenates from uninfected (lane
1) and CJD-infected (3, 6, 9 and 12 mL; lanes 2–5, respectively) brains
were incubated as indicated, without (lane 1) and with the R30 fraction
from the Superdex 200 preparative grade gel filtration column, for
20 min at 92uC. The proteins were separated by SDS-PAGE and
transferred to nitrocellulose membranes. The immunoreactive species
were detected as described in Materials and Methods, with the EB8 anti-
PrP (N-terminal) monoclonal antibody used as the primary antibody. B.
Diluted (20x) post-nuclear homogenates from CJD-infected brain were
incubated as indicated, without (lane 1) or with (lane 2) the R30 fraction
from the Superdex 200 preparative grade gel filtration column, for
20 min at 92uC. The proteins were dot blotted onto nitrocellulose
membranes. The immunoreactive species were detected as described in
Materials and Methods, with the C7/5 anti-PrP (C-terminal) and the 6H4
anti-PrP monoclonal antibody used as the primary antibodies, as
indicated.
doi:10.1371/journal.pone.0039548.g003
Figure 4. Detection of phosphotungstate-precipitable PrP. Post-nuclear homogenates from CJD-infected brain were incubated as indicated,
without (lane 1) or with (lane 2) 0.75 mg proteinase K (PK), for 20 min at 37uC, or without (lane 3) or with (lane 4) the R30 fraction from the Superdex
200 preparative grade gel filtration column, for 20 min at 92uC. Following NaPTA precipitation as described in Materials and Methods, the proteins
were separated by SDS-PAGE and transferred to nitrocellulose membranes. The immunoreactive species were detected as described in Materials and
Methods, with the 6H4 anti-PrP monoclonal antibody.
doi:10.1371/journal.pone.0039548.g004
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from the R30 Fraction
The R30 fraction from the Superdex 200 preparative grade gel
filtration column was further purified using a monoQ column, as
described in Materials and Methods. The purification steps from
the crude extract to this purified pernisine are summarized in
Table 1. This pernisine protease was purified 9.7-fold, with a final
17% yield, and with a specific activity of 2091 U/mg protein. In
Fraction R30 there are clearly visible two distinctive protein bands
with molecular masses (MW) of 34 kDa and 23 kDa (Fig. 5A, lane
2, IV, VI) and low intensity bands at 46 kDa (lane 2, I) and
10 kDa (Fig. 5A, lane 2). Further purification of this R30 fraction
using monoQ ion-exchange chromatography highlighted protein
bands at 23 kDa and at around 34 kDa (Fig. 5A, lane 3, III, IV).
Activity staining showed that the R30 fraction and the additionally
purified post-monoQ fraction both contained a proteolytically
active band, as estimated from a zymogram gel (Fig. 5B, lanes 5,
6), with a MW of around 23 kDa (Fig. 5A) and at 34 kDa,
observed only in purified pernisine.
Mass spectrometry analysis revealed that bands I and IV of
Figure 5A, lane 2, contained fragments from pernisine. The other
bands contained various fragments from other A. pernix proteins:
ABC-transporter like proteins, hypothetical proteins APE_0061
and APE_1117, and a surface-layer protein (Table S1). All of these
identified proteins are part of the extracellular fraction of proteins
from A. pernix [43,44].
Data from the SDS-PAGE, MS/MS analysis and zymography
imply that this purified pernisine has a proregion that is
autocleaved during maturation. Pernisine has a MW of 44 kDa,
as calculated from its amino-acid sequence. Based on MS/MS
data (Table S1), the protein bands with MW of 46 kDa and
34 kDa in R30 fraction (Fig. 5A, lane 2) as well as the protein
bands at 34 kDa and 23 kDa in the purified pernisine (Fig. 5A,
lane 3) correspond to the same enzyme - pernisine. According to
Figure 5, the purified pernisine is in active mature form at 23 kDa
and in pre-form at 34 kDa (Fig. 5A, lane 6). Thus, it appears that
the purified pernisin is a mixture of two different active forms,
which will have to be further analysed.
Digestion of PrP
Sc by the Purified Pernisine
As described for fraction R30, digestion of the cellular prion
protein, PrP
C, by the purified pernisine at 92uC was comparable
with that of proteinase K at 37uC (Fig. 6). A significant difference
in the proteolytic degradation was obtained when supernatants
(data not shown) of CJD brain or complete homogenates were
used (Fig. 6, panel A1). After 20 min of incubation of the PrP
Sc
samples with proteinase K, there was little digestion of the
immunoreactive material (Fig. 6, lanes 2). On the contrary, with
Table 1. Summary of the steps for the purification and identification of the pernisine from the growth medium of A. pernix K1.
Purification step
Specific activity
[U/mg protein]
# Total protein [mg] Total activity [U]
# Yield [%] Purification [fold]
Concentrated crude extract* 216 25 5400 100 1
Post S-200 (R30 fraction)
1 727 6.15 4470 83 3.4
Post monoQ (purified pernisine)
1 2091 0.44 920 17 9.7
*Note: during concentration using 10-kDa cut-off membranes, low molecular mass proteins were lost.
#One unit of protease activity is defined as the amount of enzyme that yields an increase in A366 of 0.1 O.D. under the relevant experimental conditions.
1As used in the present study.
doi:10.1371/journal.pone.0039548.t001
Figure 5. SDS-PAGE analysis and zymography through the purification steps of the medium from A. pernix. Representative gels of
medium samples through the purification, following electrophoresis on standard 12% SDS-PAGE (A) and on 12% SDS-PAGE with casein as substrate
for zymography activity (B: 4 h at 80uC), with staining with Simplyblue dye. Lanes 0, protein MW markers (as indicated left); lanes 1 and 4,
concentrated medium fraction; lanes 2 and 5, R30 fraction from the Superdex 200 preparative grade gel filtration column; and lanes 3 and 6, the post-
monoQ purified pernisine fraction (see Table 1). Lane 2, I-VI, selected protein bands of R30 fraction taken for MS/MS analysis.
doi:10.1371/journal.pone.0039548.g005
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mixtures was again below the detection level of Western blotting
(Fig. 6, lanes 4). The proteolytic activity of pernisine also did not
depend on the species of origin of the PrP used (Fig. 6, panels A1,
B, C). The activities of proteinase K and pernisine were also tested
against the protein from amyloid plaques typical for human
Alzheimer’s disease (Fig. 6, panel A2). Here, again, the pernisine
digested the immunoreactive material from the reaction mixtures
Figure 6. Digestion of PrP
C and PrP
Sc of different species by purified pernisine. Post-nuclear homogenates from human (A), bovine (B) and
mouse (C), TSE infected (lanes 1 to 4) and Alzheimer’s disease (lanes 5 to 8) brains were incubated as indicated, without (lanes 1, 5) or with (lanes 2, 6)
0.75 mg proteinase K (PK), for 20 min at 37uC, or without (lanes 3, 7) or with (lanes 4, 8) pernisine for 20 min at 92uC. The proteins were separated by
SDS-PAGE and transferred to nitrocellulose membranes. The immunoreactive species were detected as described in Materials and Methods, with the
6H4 anti-PrP monoclonal antibody used as the primary antibody.
doi:10.1371/journal.pone.0039548.g006
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lane 8), although the same was observed for proteinase K (Fig. 3,
panel A2, lane 6).
Effects of CaCl2 and NaCl on the Enzymatic Activity
Figure 7A shows the results for the relative activity of this
purified pernisine at 92uC and pH 8.0 according to the addition of
increasing concentrations of CaCl2 (0–8 mM). The maximum
enhancement of the purified pernisine activity was observed at
around 1 mM CaCl2. Further increasing the CaCl2 above 1 mM
led to a gradual decline in this enhanced activity. Similar
enhancement of CaCl2 on enzyme activity was reported for
aeropyrolysine, another heat-stable extracellular protease from
A. pernix K1 [45].
The effects of increasing concentrations of NaCl (0–500 mM)
on the relative activity of the purified pernisine in the absence and
presence of 1 mM CaCl2 are presented in Figure 6B. The
maximal activity in the absence of added CaCl2 was seen with
20 mM NaCl. As the concentration of NaCl was increased from
0 mM to 500 mM, the proteolytic activity of the purified pernisine
decreased by more than 50%. The initially higher activity in the
presence of 1 mM CaCl2 showed a decrease with the addition of
NaCl, although this was seen as only around 10% over the same
concentration range of NaCl (Fig. 7B). The maximal activity of the
purified pernisine seen for 20 mM NaCl in the absence of 1 mM
CaCl2 increased to more than two-fold after the addition of CaCl2,
with even larger relative enhancement by CaCl2 at higher NaCl
concentrations (Fig. 7B).
Single charged electrolytes like NaCl can have influences on
charged groups on the surface of a protein [46], which can be
Figure 7. Azocasein assays of the purified pernisine: effects of CaCl2 and NaCl. Relative activities of the purified pernisine according to
increasing CaCl2 concentrations (A), and according to increasing NaCl concentrations in the presence (gray, dot-dash line) and absence (black line) of
1 mM CaCl2 (B). Assays were carried out in 50 mM Tris/HCl, pH 8.0, with 0.1% (w/v) azocasein, for 20 min at 92uC. Data are means 6 SD from three
independent experiments. The lines shown represent the best fit of the data according to OriginPro 8.0 program.
doi:10.1371/journal.pone.0039548.g007
Figure 8. Azocasein assays of the purified pernisine: effects of temperature and pH. Relative activities of the purified pernisine in the
presence (gray dashed lines) and absence (black lines) of 1 mM CaCl2 according to temperature (A), in 50 mM Tris/HCl, pH 8.0, and according to pH
(B), in 50 mM glycine/HCl, pH 2 to 5, 50 mM HEPES, pH 6 to 8, or 50 mM glycine/NaOH, pH 9 to 11, at 92uC. Assays were carried out for 20 min. Data
are means 6 SD from three independent experiments. The lines shown represent the best fit of the data according to OriginPro 8.0 program.
doi:10.1371/journal.pone.0039548.g008
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catalytically active site. The further increases in the concentration
of NaCl (as ionic strength) might affect such charges near to the
active site. Indeed, the net charge of a protein depends on the ionic
strength, pH, salt type, salt concentration, and ionic valence.
Altogether, changes to the charge of a protein can have influences
on its thermostability, solubility and biological activity [46]. We
can also conclude here that NaCl and CaCl2 together do not show
any cumulative effects, as they appear to separately affect the
activity, reflecting their relatively different effects on enzyme
stabilization and/or kinetics.
Effects of Temperature and pH on the Enzymatic Activity
The effect of temperature on the proteolytic activity of the
purified pernisine was examined in the absence and presence of
1 mM CaCl2 (Fig. 8A), using the azocasein assay at pH 8.0 (in
50 mM Tris/HCl). The purified pernisine showed proteolytic
activity in the broad temperature range from 70uCt o9 5 uC, with
the maximal activity at around 85.060.5uC. In the presence of
1 mM CaCl2, the proteolytic activity of pernisine was enhanced,
to reach around 75% greater activity, with the maximum activity
at 105.060.5uC (Fig. 8A).
The shift in the temperature optimum in the presence of CaCl2
has already been described for pernisine [42] and for some other
proteins: e.g. aeropyrolysine [45], recombinant tengconlysine [47]
and aqualysin I [48]. The effects of pH on the enzymatic activity
of the purified pernisine at 92uC are shown in Figure 8B. The
activity of pernisine at 92uC was detected (.20%) in the broad
range from pH 3.5 to 8.0, with a pH optimum at 7.060.2. In the
presence of 1 mM CaCl2, there was significantly enhanced activity
of the purified pernisine observed in the wide pH range from 3 to
10 (Fig. 8B), with the pH optimum at 6.5.
The enzymatic activity of pernisine at different temperatures
(70uC and 90uC) in the presence and absence of Ca
2+ ions at
pH 8.0 for prolonged incubation times (0 min, 20 min, 40 min,
Figure 9. Thermostability of pernisine. Residual activity of pernisine incubated at different temperatures (70uC and 90uC) in the presence and
absence of Ca
2+ ions at pH 8.0 for prolonged incubation times (0 min, 20 min, 40 min, 120 min) as marked.
doi:10.1371/journal.pone.0039548.g009
Table 2. Residual protease activity of the purified pernisine in the absence and presence of CaCl2 and protease inhibitors.
Inhibitor
Concentration
added [mM] Class of inhibitor
Residual protease activity
without CaCl2 [%]
Residual protease activity with
1 mM CaCl2 [%]
None – – 100 216
EDTA 1 Metalloprotease 3 202
50 1
EGTA 1 Metalloprotease 1 197
50 3
PMSF 1 Serine protease 7 15
10 2 6
Iodoacetamide 10 Cysteine protease 103 198
doi:10.1371/journal.pone.0039548.t002
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presence of Ca
2+ ions. In the absence of Ca
2+ decreasing of
residual proteolytic activity over time was observed (Figure 9).
Based on these observations we can conclude that pernisine is
thermally stable protease.
Effects of Protease Inhibitors on the Enzymatic Activity
Different inhibitors (Table 2) were used to test for their effects
on the protease activity of the purified pernisine. These included
inhibitors of metalloproteases and serine and cysteine proteases, as
specified in Table 2. EDTA, EGTA and PMSF had the greatest
inhibitory effects on the purified pernisine activity, which confirms
that it is a metalloprotease and serine protease. Addition of 1 mM
EDTA or EGTA to the purified pernisine in the absence of added
CaCl2 effectively completely inhibited the protease activity of the
purified pernisine (Table 2). However, in the presence of 1 mM
CaCl2, 1 mM EDTA and EGTA had no significant effects, with
the need for higher (5 mM) EDTA and EGTA for complete
inhibition of the purified pernisine. In contrast, as a serine protease
inhibitor, PMSF (1 mM, 10 mM) effectively blocked this activity
both in the presence and absence of 1 mM CaCl2, while IAA as a
cysteine protease inhibitor showed no inhibition here, even at
10 mM.
Its is likely that EDTA and EGTA affect this purified pernisine
activity not only by extracting the Ca
2+ ions, which could lead to
denaturation of the protein, but also by influencing the autolysis of
the purified pernisine, as implied by Catara et al. [42]. Thus, it is
likely that some Ca
2+ ions will already be coordinated with this
purified pernisine, similar to what has been shown for Tk-SP: Ca
2+
is bound too tightly to Tk-SP to be removed with extensive dialysis
against Ca
2+-free buffer, but it can be removed by treatment with
10 mM EDTA [49].
Effects of Denaturing Agents on the Enzymatic Activity
Table 3 gives the data for the residual purified pernisine activity
in the presence of further reagents: two reductants (DTT and 2-
mercaptoethanol), two denaturants (GdnHCl and urea) and a
detergent (SDS). With the purified pernisine in the absence of
1 mM CaCl2, at both 1 mM and 5 mM, DTT showed about 65%
inhibition of the purified pernisine activity, which was slightly
reduced, to around 45% inhibition, in the presence of 1 mM
Table 3. Residual protease activity of the purified pernisine in the absence and presence of CaCl2 and reductants, denaturants and
detergent.
Reagent Concentration added Class of reagent
Residual protease activity
without CaCl2 [%]
Residual protease activity with
1 mM CaCl2 [%]
None – – 100 201
Dithiothreitol 1 mM Reductant 35 56
5m M 3 4 5 2
2-mercaptoethanol 1% Reductant 48 70
5% 39 62
Guanidine HCl 1 M Denaturant 27 133
4 M 35 306
Urea 1 M Denaturant 52 104
4M 5 0 9 4
SDS 0.1% Detergent 69 132
3.0% 20 68
doi:10.1371/journal.pone.0039548.t003
Figure 10. Model of the three-dimensional structure of
pernisine. Proposed proregion (black; Val1-Met62) and mature (gray;
Ala63-Val396) forms. Model structure was built using the Geno3D2
program. Note: part of the N-terminal of the amino-acid sequence (M1-
V32) is missing.
doi:10.1371/journal.pone.0039548.g010
Enzymatic Degradation of PrP
Sc
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39548CaCl2 (Table 3). Similar effects were seen for 2-mercaptoethanol,
with about 55% and 35% inhibition, respectively (Table 3).
For the denaturants, in the presence of 1 mM CaCl2,1M
GdnHCl showed greater inhibition of the purified pernisine
compared to 4 M urea (residual activities, 27% vs. 50%,
respectively). Of note, at the higher GdnHCl of 4 M, this also
decreases the pH, which reflects on the change in the enzyme
activity. Similarly, this might also be related to the case of addition
of CaCl2 here, where 4 M GdnHCl increased the enzyme activity
over and above the Ca
2+ effect (Table 3). However, it is also
known that some denaturants can affect enzyme active sites,
promoting faster catalysis [47].
The purified pernisine remains relatively active with a low SDS
concentration (0.1%), both in the absence and presence of 1 mM
CaCl2, with residual activity also remaining with the addition of
3% SDS (Table 3).
Discussion
In the present study, we have shown that pernisine is the
proteolytic enzyme that we have purified from the growth medium
of A. pernix and that can digest PrP
Sc that is resistant to degradation
by proteinase K. The R30 fraction and the purified pernisine can
digest PrP
Sc from different species (bovine, mouse, human)
(Figures 2, 6 A1), as well as protein plaques in Alzheimer disease
(Figures 2, 6, A2). Thus our analysis of the fraction (R30) and
purified enzyme (Table S1) by MS/MS identified pernisine as the
active enzyme.
Catara et al. [42] identified pernisine by SDS-PAGE and gel
filtration, and they determined its proteolytic activity by SDS-
PAGE with casein overlay. In their study, the recombinant
pernisine was expressed in Escherichia coli, and the data suggested
that it has a proregion. Our data in the present study also indicate
that the purified pernisine is likely to have a proregion, as was seen
for the similar protease Tk-subtilisin [50], and for other bacterial
subtilisins [38]. The alignment of the amino-sequence of pernisine
with Tk-subtilisin showed 51.7% identity and 66.5% consensus in
their sequences. Tk-subtilisin has a signal sequence M
1-A
24 and a
prosequence G
25-L
93. Analysis of the amino-sequence of pernisine
using the SignaIP 3.0 program, which uses neural networks and
hidden Markov models that are trained on eukaryotes, leads us to
propose that pernisine has a M
1-G
24 signal sequence. From an
alignment of pernisine with Tk-subtilisin, we propose a prose-
quence of S
25-M
94. This prediction is in agreement with the data
from SDS-PAGE of the purified pernisine, with the two bands
seen corresponding the MWs of 45 kDa with the proregion, and
34 kDa without it (Figure 10). The active form of pernisine
observed at 23 kDa at higher protein concentrations could be the
result of further autocatalytic activity of pernisine, similarly as it
was reported before for Tk-SP [38]. By following the changes in
the enzymatic activity under a broad range of temperature for
prolonged incubation times (Figure 9), we can conclude that
pernisine is a thermostable metalloprotease that is compatible with
other thermostable enzymes that have already been described,
such as: Tk-subtilisin and Tk-SP from T. kodakaraensis [49],
aerolysine from A. pernix [45], and Aqualysin I from Thermus
aquaticus YT-1 [48].
Pernisine is a serine metalloprotease that is active in the
temperature range from 60uCt o9 9 uC, in the pH range from 3.5
to 8.0, and at NaCl concentrations from 0 mM to 500 mM. Its
enzymatic activity optimum is at 85.060.5uC, pH 7.060.25 and
20 mM NaCl. The presence of 1 mM CaCl2 increases the
enzymatic activity to azocasein by two-fold, and shifts the activity
optimum to 10561uC and the pH optimum to 6.560.2. In the
presence of 1 mM CaCl2, the purified pernisine maintains its
enzymatic activity at NaCl concentrations of 0 mM to 500 mM,
while with 5 mM EDTA or EGTA, the purified pernisine is
completely inhibited. This purified pernisine activity is not
restored here even after addition of 1 mM CaCl2. Furthermore,
the purified pernisine is inhibited by the serine protease inhibitor
PMSF.
Based on our biochemical characterization of the purified
pernisine, we can conclude that CaCl2 has a crucial role in the
proteolytic activity at higher temperatures. This broad range of
pH and temperature activity of pernisine can thus be exploited for
different biotechnological and industrial applications in the food
industry, in decontamination processes of wastes, in the leather
industry, and in the degradation of infective protein aggregates
[38].
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data of identified proteins of specific bands are presented in the
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